showed that, in patients with non-small cell lung cancer, tumor-infiltrating NK cells express several activation markers, including NKp44, CD69, and HLA-DR, yet showed profoundly impaired cytotoxic potential (19). This evidence concerns the gene NCR2 and neoplasm.